M. D. Anderson Cancer Center - News Releases This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Lynda Chin Selected as UT System Chancellor's Health Fellow
The University of Texas System named MD Anderson scientist Lynda Chin, M.D., as a recipient of the System's prestigious Chancellor's Health Fellowship.  (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - June 26, 2014 Category: Cancer & Oncology Source Type: news

Diane Barber receives MD Anderson's highest nursing honor
Diane Barber, Ph.D., of The University of Texas MD Anderson Cancer Center, is the recipient of the 2014 Ethel Fleming Arceneaux Outstanding Nurse-Oncologist Award. The Brown Foundation, Inc. established the award in 1982 as the institution's highest nursing honor. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - June 23, 2014 Category: Cancer & Oncology Source Type: news

Biology to Bedside: Mining Molecular Data for Cancer Prognosis
How will any one patient fare with their cancer treatment program? It's a question with no easy answer. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - June 22, 2014 Category: Cancer & Oncology Source Type: news

MD Anderson professor wins notable AAAS award
Li Ma, Ph.D., assistant professor of Experimental Radiation Oncology at The University of Texas MD Anderson Cancer Center, has been named co-winner of a distinguished award by the American Association for the Advancement of Science (AAAS).  (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - June 20, 2014 Category: Cancer & Oncology Source Type: news

Statement regarding release of data prior to study conclusion
The following is a statement from The University of Texas MD Anderson Cancer Center in response to several inquiries about news coverage this week. The news coverage pertains to research data from a clinical trial released by a biotech company before the clinical trial was completed. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - June 20, 2014 Category: Cancer & Oncology Source Type: news

Allison shares inaugural Tang Prize for his cancer immunotherapy innovation
The first Tang Prize for Biopharmaceutical Science has been awarded to Jim Allison, Ph.D., chair of Immunology at The University of Texas MD Anderson Cancer Center and Tasuku Honjo, M.D., Ph.D., of Japan's Kyoto University for their research leading to cancer immunotherapy.  (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - June 20, 2014 Category: Cancer & Oncology Source Type: news

New target: Researchers identify pancreatic cancer resistance mechanism
Pancreatic cancer tumors addicted to mutant Kras signaling for their growth and progression have a ready-made substitute to tap if they're ever forced to go cold-turkey on the mutant oncogene, scientists at The University of Texas MD Anderson Cancer Center report in the journal Cell. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - June 19, 2014 Category: Cancer & Oncology Source Type: news

African American women with breast cancer less likely to have newer, recommended surgical procedure, MD Anderson study finds
African American women with early stage, invasive breast cancer were 12 percent less likely than Caucasian women with the same diagnosis to receive a minimally invasive technique, axillary sentinel lymph node (SLN) biopsy, even as the procedure had become the standard of surgical practice, according to research from The University of Texas MD Anderson Cancer Center. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - June 18, 2014 Category: Cancer & Oncology Source Type: news

Needle biopsy underused in breast cancer diagnosis, negatively impacting diagnosis and care
Needle biopsy, the standard of care radiological procedure for diagnosing breast cancer, is underused with too many patients undergoing the more invasive, excisional biopsy to detect their disease, according to research from The University of Texas MD Anderson Cancer Center.   (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - June 9, 2014 Category: Cancer & Oncology Source Type: news

American Society of Clinical Oncology recognizes MD Anderson leaders for their contributions to cancer care
Cancer research and treatment has evolved significantly in the past five decades. As the American Society of Clinical Oncology (ASCO) celebrates its 50th anniversary, the organization named former MD Anderson president John Mendelsohn, M.D., Waun Ki Hong, M.D., and Gabriel Hortobagyi, M.D. to its list of luminaries.   (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - June 2, 2014 Category: Cancer & Oncology Source Type: news

Patients with metastatic colon cancer respond to new combination therapy
In an aggressive disease known for poor response rates, researchers from The University of Texas MD Anderson Cancer Center found patients with advanced colorectal cancer responded well to a combination therapy of the drugs vermurafenib, cetuximab and irinotecan. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - May 31, 2014 Category: Cancer & Oncology Source Type: news

New software tool identifies genetic mutations that influence disease risk
Researchers at The University of Texas MD Anderson Cancer Center and other institutions have applied a newly developed software tool to identify genetic mutations that contribute to a person's increased risk for developing common, complex diseases, such as cancer. T (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - May 30, 2014 Category: Cancer & Oncology Source Type: news

Women with metastatic breast cancer can safely receive bisphosphonates less frequently, without compromising care
Women with metastatic breast cancer to the bone may be able to receive bisphosphonates, the bone-targeting class of drugs like zoledronic acid, less often after the first year of monthly administration. With that practice change, they may also reduce their risk of serious side effects, according to a study led by researchers at The University of Texas MD Anderson Cancer Center. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - May 30, 2014 Category: Cancer & Oncology Source Type: news

A Conversation With a Living Legend® raises more than $1 million
Dr. Condoleezza Rice was the honoree of The University of Texas MD Anderson Cancer Center's A Conversation With a Living Legend®, Wednesday, May 21 at the Westin Galleria. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - May 28, 2014 Category: Cancer & Oncology Source Type: news

Intensity Modulated Proton Therapy Shows Benefit for Head and Neck Cancer
In a small study, researchers from The University of Texas MD Anderson Cancer Center found that 93 percent of head and neck cancer patients treated with multi-field optimization intensity modulated proton therapy (MFO-IMPT) were cancer-free 28 months after treatment. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - May 27, 2014 Category: Cancer & Oncology Source Type: news